Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-15

FDA Approved: FOSAMPRENAVIR CALCIUM — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic version of fosamprenavir calcium for the treatment of HIV infection, via Mylan's ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosamprenavir calcium (fosamprenavir calcium)

Snippet

ORIG AP for FOSAMPRENAVIR CALCIUM (FOSAMPRENAVIR CALCIUM)